Next Frontier Advisors
Ted (Theodore) Schenkelberg is a seasoned professional in the fields of biomedical product development and global health, currently serving as the Managing Partner at Next Frontier Advisors. With extensive experience, including roles as Senior Vice President and Chief Strategy Officer at the Human Immunome Project, and Co-Founder of organizations such as MyImmunome and the Human Immunome Project Dutch Foundation, Ted has played a pivotal role in advancing vaccine and therapeutic development using innovative approaches. Previous positions also include significant contributions to the International AIDS Vaccine Initiative, and strategic advisory roles in global health initiatives. Ted holds a Master of Public Health from Johns Hopkins and an MBA from the University of Chicago, complemented by an undergraduate degree from Grinnell College and additional studies at The London School of Economics.
This person is not in any teams
This person is not in any offices
Next Frontier Advisors
Next Frontier Advisors is a scientific consulting firm that delivers strategic advisory services to optimize and advance R&D for improved global health. NFA is built around a network model that harnesses decades of technical and functional expertise from industry and academia. We support commercial, philanthropic, and non-profit clients with end-to-end advisory services for vaccines and other biologics – from early-stage research to licensure and roll-out. Our approach ensures clients receive bespoke, evidence-based support tailored to the rapidly evolving research ecosystem. At the core of our business model lies a diverse pool of professionals who have spent decades at the forefront of their respective fields. Our network includes former industry leaders, academic experts, research scientists, and non-profit executives, each bringing a wealth of experience, deep technical knowledge, and vast experience to help clients achieve organizational goals.